{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:33Z","timestamp":1792801473579,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073149"],"award-info":[{"award-number":["82073149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472893"],"award-info":[{"award-number":["82472893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515220219"],"award-info":[{"award-number":["2022A1515220219"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Perineural invasion (PNI) is a hallmark feature of pancreatic ductal adenocarcinoma (PDAC), which occurs at a high incidence and significantly contributes to PDAC lethality and poor survival. Despite its prevalence and association with poor prognosis, the molecular mechanisms underlying PNI in PDAC remain unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We investigated clinical samples from two cohorts by UPLC\/MS-MS to profiled significantly altered chemical RNA modifications in PDAC tissues with PNI lesions. Dorsal root ganglion coculture systems and sciatic nerve injection models validated PNI ability. We combined RNA-seq, acRIP-seq and ac4C-seq with CRISPR-based techniques to explore the regulatory mechanism of ac4C modification on the integrin beta 5 (<jats:italic>ITGB5<\/jats:italic>) transcript.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result<\/jats:title>\n            <jats:p>We reported that N<jats:sup>4<\/jats:sup>-acetylcytidine (ac4C) is a significantly altered chemical RNA modification in PDAC tissues with PNI lesions. In vitro and in vivo models demonstrated that tumor cells overexpression of N-acetyltransferase 10 (NAT10), the writer enzyme of mRNA ac4C modification, enhances PNI in PDAC. Further analysis revealed decreased ac4C levels on transcripts of the focal adhesion pathway, particular on ITGB5, in NAT10-knockdown PDAC cells. This ac4C modification in the CDS region of ITGB5 mRNA promotes its stability, subsequently activating the ITGB5-pFAK-pSrc pathway. CRISPR-based analysis further confirmed the crucial role of NAT10-mediated ac4C modification in regulating ITGB5 expression. Combining small-molecule inhibitors targeting NAT10 and focal adhesion kinase (FAK) significantly attenuated PNI in vivo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings reveal a previously unrecognized ac4C-mediated epigenetic mechanism in PNI and propose a novel therapeutic strategy to improve survival in PDAC patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>One-sentence summary<\/jats:title>\n            <jats:p>NAT10 promotes PNI via ac4C modification in PDAC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13046-025-03362-2","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T03:00:42Z","timestamp":1742612442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["N4-acetylcytidine modification of ITGB5 mRNA mediated by NAT10 promotes perineural invasion in pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"44","author":[{"given":"Leyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanbo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"issue":"1","key":"3362_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"3362_CR2","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2016.67.5561","volume":"34","author":"EP Balaban","year":"2016","unstructured":"Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, et al. Locally advanced, unresectable pancreatic cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(22):2654\u201368. https:\/\/doi.org\/10.1200\/JCO.2016.67.5561","journal-title":"J Clin Oncol"},{"issue":"6","key":"3362_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrc.2016.38","volume":"16","author":"M Amit","year":"2016","unstructured":"Amit M, Na\u2019Ara S, Gil Z. Mechanisms of cancer dissemination along nerves. Nat Rev Cancer. 2016;16(6):399\u2013408. https:\/\/doi.org\/10.1038\/nrc.2016.38","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"3362_CR4","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.7150\/thno.42440","volume":"10","author":"D Su","year":"2020","unstructured":"Su D, Guo X, Huang L, Ye H, Li Z, Lin L, Chen R, Zhou Q. Tumor-neuroglia interaction promotes pancreatic cancer metastasis. Theranostics. 2020;10(11):5029\u201347. https:\/\/doi.org\/10.7150\/thno.42440","journal-title":"Theranostics"},{"issue":"4","key":"3362_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41416-023-02539-w","volume":"130","author":"B Zhang","year":"2024","unstructured":"Zhang B, Guo X, Huang L, Zhang Y, Li Z, Su D, et al. Tumour-associated macrophages and Schwann cells promote perineural invasion via paracrine loop in pancreatic ductal adenocarcinoma. Br J Cancer. 2024;130(4):542\u201354. https:\/\/doi.org\/10.1038\/s41416-023-02539-w","journal-title":"Br J Cancer"},{"issue":"3","key":"3362_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41(3):573\u201380. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.012","journal-title":"Cancer Cell"},{"issue":"8","key":"3362_CR7","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, et al. Cancer neuroscience: state of the field, emerging directions. Cell. 2023;186(8):1689\u2013707. https:\/\/doi.org\/10.1016\/j.cell.2023.02.002","journal-title":"Cell"},{"issue":"7965","key":"3362_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","volume":"618","author":"R Mancusi","year":"2023","unstructured":"Mancusi R, Monje M. The neuroscience of cancer. Nature. 2023;618(7965):467\u201379. https:\/\/doi.org\/10.1038\/s41586-023-05968-y","journal-title":"Nature"},{"issue":"1","key":"3362_CR9","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1038\/s41467-019-11812-7","volume":"10","author":"G Lomberk","year":"2019","unstructured":"Lomberk G, Dusetti N, Iovanna J, Urrutia R. Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine. Nat Commun. 2019;10(1):3875. https:\/\/doi.org\/10.1038\/s41467-019-11812-7","journal-title":"Nat Commun"},{"issue":"7885","key":"3362_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41586-021-04075-0","volume":"599","author":"G Pascual","year":"2021","unstructured":"Pascual G, Dominguez D, Elosua-Bayes M, Beckedorff F, Laudanna C, Bigas C, et al. Dietary palmitic acid promotes a prometastatic memory via Schwann cells. Nature. 2021;599(7885):485\u201390. https:\/\/doi.org\/10.1038\/s41586-021-04075-0","journal-title":"Nature"},{"key":"3362_CR11","doi-asserted-by":"publisher","first-page":"848557","DOI":"10.3389\/fgene.2022.848557","volume":"13","author":"P Hurnik","year":"2022","unstructured":"Hurnik P, Chyra Z, Sevcikova T, Stembirek J, Trtkova KS, Gaykalova DA, Buchtova M, Hruba E. Epigenetic regulations of perineural invasion in head and neck squamous cell carcinoma. Front Genet. 2022;13:848557. https:\/\/doi.org\/10.3389\/fgene.2022.848557","journal-title":"Front Genet"},{"issue":"2","key":"3362_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","volume":"25","author":"S Delaunay","year":"2024","unstructured":"Delaunay S, Helm M, Frye M. Rna modifications in physiology and disease: towards clinical applications. Nat Rev Genet. 2024;25(2):104\u201322. https:\/\/doi.org\/10.1038\/s41576-023-00645-2","journal-title":"Nat Rev Genet"},{"issue":"6","key":"3362_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of Rna modifications in cancer. Nat Rev Cancer. 2020;20(6):303\u201322. https:\/\/doi.org\/10.1038\/s41568-020-0253-2","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"3362_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng X, Qing Y, Horne D, Huang H, Chen J. The roles and implications of Rna m(6)a modification in cancer. Nat Rev Clin Oncol. 2023;20(8):507\u201326. https:\/\/doi.org\/10.1038\/s41571-023-00774-x","journal-title":"Nat Rev Clin Oncol"},{"key":"3362_CR15","doi-asserted-by":"publisher","first-page":"106555","DOI":"10.1016\/j.phrs.2022.106555","volume":"187","author":"F Li","year":"2023","unstructured":"Li F, He C, Yao H, Zhao Y, Ye X, Zhou S, et al. Glutamate from nerve cells promotes perineural invasion in pancreatic cancer by regulating tumor Glycolysis through hk2 mrna-m6a modification. Pharmacol Res. 2023;187:106555. https:\/\/doi.org\/10.1016\/j.phrs.2022.106555","journal-title":"Pharmacol Res"},{"issue":"11","key":"3362_CR16","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.1007\/s11033-020-05963-w","volume":"47","author":"R Karthiya","year":"2020","unstructured":"Karthiya R, Wasil SM, Khandelia P. Emerging role of n4-acetylcytidine modification of Rna in gene regulation and cellular functions. Mol Biol Rep. 2020;47(11):9189\u201399. https:\/\/doi.org\/10.1007\/s11033-020-05963-w","journal-title":"Mol Biol Rep"},{"issue":"4","key":"3362_CR17","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/nar\/gkv075","volume":"43","author":"S Sharma","year":"2015","unstructured":"Sharma S, Langhendries JL, Watzinger P, Kotter P, Entian KD, Lafontaine DL. Yeast kre33 and human nat10 are conserved 18s Rrna cytosine acetyltransferases that modify Trnas assisted by the adaptor tan1\/thumpd1. Nucleic Acids Res. 2015;43(4):2242\u201358. https:\/\/doi.org\/10.1093\/nar\/gkv075","journal-title":"Nucleic Acids Res"},{"issue":"52","key":"3362_CR18","doi-asserted-by":"publisher","first-page":"35724","DOI":"10.1074\/jbc.C114.602698","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito S, Horikawa S, Suzuki T, Kawauchi H, Tanaka Y, Suzuki T, Suzuki T. Human nat10 is an atp-dependent Rna acetyltransferase responsible for n4-acetylcytidine formation in 18 s ribosomal Rna (rrna). J Biol Chem. 2014;289(52):35724\u201330. https:\/\/doi.org\/10.1074\/jbc.C114.602698","journal-title":"J Biol Chem"},{"issue":"7","key":"3362_CR19","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango D, Sturgill D, Alhusaini N, Dillman AA, Sweet TJ, Hanson G, et al. Acetylation of cytidine in Mrna promotes translation efficiency. Cell. 2018;175(7):1872\u2013e188624. https:\/\/doi.org\/10.1016\/j.cell.2018.10.030","journal-title":"Cell"},{"issue":"15","key":"3362_CR20","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango D, Sturgill D, Yang R, Kanai T, Bauer P, Roy J, Wang Z, Hosogane M, Schiffers S, Oberdoerffer S. Direct epitranscriptomic regulation of mammalian translation initiation through n4-acetylcytidine. Mol Cell. 2022;82(15):2797\u2013e281411. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.016","journal-title":"Mol Cell"},{"issue":"5","key":"3362_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","volume":"33","author":"L Liao","year":"2023","unstructured":"Liao L, He Y, Li SJ, Yu XM, Liu ZC, Liang YY, et al. Lysine 2-hydroxyisobutyrylation of nat10 promotes cancer metastasis in an ac4c-dependent manner. Cell Res. 2023;33(5):355\u201371. https:\/\/doi.org\/10.1038\/s41422-023-00793-4","journal-title":"Cell Res"},{"issue":"1","key":"3362_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jing Y, Wang Y, Tang J, Zhu X, Jin W, Wang Y, Yuan W, Li X, Li X. Nat10 promotes gastric cancer metastasis via n4-acetylated col5a1. Signal Transduct Target Therapy. 2021;6(1):173. https:\/\/doi.org\/10.1038\/s41392-021-00489-4","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"3362_CR23","doi-asserted-by":"publisher","first-page":"113620","DOI":"10.1016\/j.yexcr.2023.113620","volume":"428","author":"G Zong","year":"2023","unstructured":"Zong G, Wang X, Guo X, Zhao Q, Wang C, Shen S, et al. Nat10-mediated Axl Mrna n4-acetylcytidine modification promotes pancreatic carcinoma progression. Exp Cell Res. 2023;428(2):113620. https:\/\/doi.org\/10.1016\/j.yexcr.2023.113620","journal-title":"Exp Cell Res"},{"issue":"15","key":"3362_CR24","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/cncr.24396","volume":"115","author":"C Liebig","year":"2009","unstructured":"Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer-Am Cancer Soc. 2009;115(15):3379\u201391. https:\/\/doi.org\/10.1002\/cncr.24396","journal-title":"Cancer-Am Cancer Soc"},{"issue":"10","key":"3362_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc3131","volume":"11","author":"AA Bapat","year":"2011","unstructured":"Bapat AA, Hostetter G, Von Hoff DD, Han H. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer. 2011;11(10):695\u2013707. https:\/\/doi.org\/10.1038\/nrc3131","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"3362_CR26","doi-asserted-by":"publisher","first-page":"112810","DOI":"10.1016\/j.celrep.2023.112810","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang S, Han H, Wang X, Zheng S, Wang Z, et al. Nat10-mediated ac4c Trna modification promotes Egfr Mrna translation and gefitinib resistance in cancer. Cell Rep. 2023;42(7):112810. https:\/\/doi.org\/10.1016\/j.celrep.2023.112810","journal-title":"Cell Rep"},{"issue":"2","key":"3362_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.chom.2020.05.011","volume":"28","author":"K Tsai","year":"2020","unstructured":"Tsai K, Jaguva Vasudevan AA, Martinez Campos C, Emery A, Swanstrom R, Cullen BR. Acetylation of cytidine residues boosts hiv-1 gene expression by increasing viral Rna stability. Cell Host Microbe. 2020;28(2):306\u2013e3126. https:\/\/doi.org\/10.1016\/j.chom.2020.05.011","journal-title":"Cell Host Microbe"},{"issue":"4","key":"3362_CR28","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1038\/s41596-021-00501-9","volume":"16","author":"GS Thalalla","year":"2021","unstructured":"Thalalla GS, Sas-Chen A, Schwartz S, Meier JL. Quantitative nucleotide resolution profiling of Rna cytidine acetylation by ac4c-seq. Nat Protoc. 2021;16(4):2286\u2013307. https:\/\/doi.org\/10.1038\/s41596-021-00501-9","journal-title":"Nat Protoc"},{"issue":"7817","key":"3362_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41586-020-2418-2","volume":"583","author":"A Sas-Chen","year":"2020","unstructured":"Sas-Chen A, Thomas JM, Matzov D, Taoka M, Nance KD, Nir R, et al. Dynamic Rna acetylation revealed by quantitative cross-evolutionary mapping. Nature. 2020;583(7817):638\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2418-2","journal-title":"Nature"},{"issue":"1","key":"3362_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrm1549","volume":"6","author":"SK Mitra","year":"2005","unstructured":"Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 2005;6(1):56\u201368. https:\/\/doi.org\/10.1038\/nrm1549","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6183","key":"3362_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.1252651","volume":"344","author":"D Larrieu","year":"2014","unstructured":"Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP. Chemical Inhibition of nat10 corrects defects of laminopathic cells. Science. 2014;344(6183):527\u201332. https:\/\/doi.org\/10.1126\/science.1252651","journal-title":"Science"},{"issue":"7","key":"3362_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc1647","volume":"5","author":"GW Mclean","year":"2005","unstructured":"Mclean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer. 2005;5(7):505\u201315. https:\/\/doi.org\/10.1038\/nrc1647","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3362_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ncb1094","volume":"6","author":"DJ Webb","year":"2004","unstructured":"Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. Fak-src signalling through paxillin, Erk and Mlck regulates adhesion disassembly. Nat Cell Biol. 2004;6(2):154\u201361. https:\/\/doi.org\/10.1038\/ncb1094","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3362_CR34","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/s41467-021-21858-1","volume":"12","author":"DMT Hurtado","year":"2021","unstructured":"Hurtado DMT, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, et al. Tumor-penetrating therapy for beta5 integrin-rich pancreas cancer. Nat Commun. 2021;12(1):1541. https:\/\/doi.org\/10.1038\/s41467-021-21858-1","journal-title":"Nat Commun"},{"key":"3362_CR35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-3638","author":"D Su","year":"2024","unstructured":"Su D, Wang R, Chen G, Ding C, Liu Y, Tao J, et al. Fbxo32 stimulates protein synthesis to drive pancreatic cancer progression and metastasis. Cancer Res. 2024. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3638","journal-title":"Cancer Res"},{"issue":"1","key":"3362_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, Gu Y, Zhao N, Xiang Q, Cui Y. Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther. 2023;8(1):1. https:\/\/doi.org\/10.1038\/s41392-022-01259-6","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"3362_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrg3160","volume":"13","author":"DR Schoenberg","year":"2012","unstructured":"Schoenberg DR, Maquat LE. Regulation of cytoplasmic Mrna decay. Nat Rev Genet. 2012;13(4):246\u201359. https:\/\/doi.org\/10.1038\/nrg3160","journal-title":"Nat Rev Genet"},{"issue":"9","key":"3362_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41589-019-0327-1","volume":"15","author":"XM Liu","year":"2019","unstructured":"Liu XM, Zhou J, Mao Y, Ji Q, Qian SB. Programmable Rna n(6)-methyladenosine editing by crispr-cas9 conjugates. Nat Chem Biol. 2019;15(9):865\u201371. https:\/\/doi.org\/10.1038\/s41589-019-0327-1","journal-title":"Nat Chem Biol"},{"issue":"678","key":"3362_CR39","doi-asserted-by":"publisher","first-page":"eabl7895","DOI":"10.1126\/scitranslmed.abl7895","volume":"15","author":"L Su","year":"2023","unstructured":"Su L, Chen Y, Huang C, Wu S, Wang X, Zhao X, et al. Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. Sci Transl Med. 2023;15(678):eabl7895. https:\/\/doi.org\/10.1126\/scitranslmed.abl7895","journal-title":"Sci Transl Med"},{"issue":"13","key":"3362_CR40","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1002\/anie.201707948","volume":"57","author":"R Hatley","year":"2018","unstructured":"Hatley R, Macdonald S, Slack RJ, Le J, Ludbrook SB, Lukey PT. An alphav-rgd integrin inhibitor toolbox: drug discovery insight, challenges and opportunities. Angew Chem Int Ed Engl. 2018;57(13):3298\u2013321. https:\/\/doi.org\/10.1002\/anie.201707948","journal-title":"Angew Chem Int Ed Engl"},{"key":"3362_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.actbio.2014.10.008","volume":"11","author":"NH Romano","year":"2015","unstructured":"Romano NH, Madl CM, Heilshorn SC. Matrix Rgd ligand density and l1cam-mediated Schwann cell interactions synergistically enhance neurite outgrowth. Acta Biomater. 2015;11:48\u201357. https:\/\/doi.org\/10.1016\/j.actbio.2014.10.008","journal-title":"Acta Biomater"},{"issue":"4","key":"3362_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1083\/jcb.200101099","volume":"155","author":"S Mechtersheimer","year":"2001","unstructured":"Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, Riedle S, et al. Ectodomain shedding of l1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol. 2001;155(4):661\u201373. https:\/\/doi.org\/10.1083\/jcb.200101099","journal-title":"J Cell Biol"},{"issue":"4","key":"3362_CR43","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41388-018-0458-y","volume":"38","author":"S Na\u2019Ara","year":"2019","unstructured":"Na\u2019Ara S, Amit M, Gil Z. L1cam induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression. Oncogene. 2019;38(4):596\u2013608. https:\/\/doi.org\/10.1038\/s41388-018-0458-y","journal-title":"Oncogene"},{"issue":"1","key":"3362_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13046-021-01892-z","volume":"40","author":"T Le Large","year":"2021","unstructured":"Le Large T, Bijlsma MF, El HB, Mantini G, Lagerweij T, Henneman AA, et al. Focal adhesion kinase Inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2021;40(1):91. https:\/\/doi.org\/10.1186\/s13046-021-01892-z","journal-title":"J Exp Clin Cancer Res"},{"key":"3362_CR45","doi-asserted-by":"publisher","unstructured":"Huyett P, Gilbert M, Liu L, Ferris RL, Kim S. A model for perineural invasion in head and neck squamous cell carcinoma. J Vis Exp 2017(119). https:\/\/doi.org\/10.3791\/55043","DOI":"10.3791\/55043"},{"issue":"12","key":"3362_CR46","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41575-022-00669-9","volume":"19","author":"N Vaes","year":"2022","unstructured":"Vaes N, Idris M, Boesmans W, Alves MM, Melotte V. Nerves in Gastrointestinal cancer: from mechanism to modulations. Nat Rev Gastroenterol Hepatol. 2022;19(12):768\u201384. https:\/\/doi.org\/10.1038\/s41575-022-00669-9","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"3362_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5694\/mja11.10890","volume":"196","author":"AG Speer","year":"2012","unstructured":"Speer AG, Thursfield VJ, Torn-Broers Y, Jefford M. Pancreatic cancer: surgical management and outcomes after 6 years of follow-up. Med J Aust. 2012;196(8):511\u20135. https:\/\/doi.org\/10.5694\/mja11.10890","journal-title":"Med J Aust"},{"issue":"2","key":"3362_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cac2.12399","volume":"43","author":"Q Lin","year":"2023","unstructured":"Lin Q, Zheng S, Yu X, Chen M, Zhou Y, Zhou Q, et al. Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial. Cancer Commun (Lond). 2023;43(2):257\u201375. https:\/\/doi.org\/10.1002\/cac2.12399","journal-title":"Cancer Commun (Lond)"},{"issue":"17","key":"3362_CR49","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1523\/JNEUROSCI.2321-22.2023","volume":"43","author":"M Zhang","year":"2023","unstructured":"Zhang M, Yang K, Wang QH, Xie L, Liu Q, Wei R, et al. The cytidine n-acetyltransferase nat10 participates in peripheral nerve injury-induced neuropathic pain by stabilizing syt9 expression in primary sensory neurons. J Neurosci. 2023;43(17):3009\u201327. https:\/\/doi.org\/10.1523\/JNEUROSCI.2321-22.2023","journal-title":"J Neurosci"},{"issue":"4","key":"3362_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41575-023-00884-y","volume":"21","author":"S Lin","year":"2024","unstructured":"Lin S, Kuang M. Rna modification-mediated Mrna translation regulation in liver cancer: mechanisms and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2024;21(4):267\u201381. https:\/\/doi.org\/10.1038\/s41575-023-00884-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"3362_CR51","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41388-022-02185-1","volume":"41","author":"QC Xu","year":"2022","unstructured":"Xu QC, Tien YC, Shi YH, Chen S, Zhu YQ, Huang XT, Huang CS, Zhao W, Yin XY. Mettl3 promotes intrahepatic cholangiocarcinoma progression by regulating ifit2 expression in an m(6)a-ythdf2-dependent manner. Oncogene. 2022;41(11):1622\u201333. https:\/\/doi.org\/10.1038\/s41388-022-02185-1","journal-title":"Oncogene"},{"issue":"6","key":"3362_CR52","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z, et al. Tumors exploit fto-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021;33(6):1221\u2013e123311. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.001","journal-title":"Cell Metab"},{"issue":"5","key":"3362_CR53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41568-021-00340-6","volume":"21","author":"JC Dawson","year":"2021","unstructured":"Dawson JC, Serrels A, Stupack DG, Schlaepfer DD, Frame MC. Targeting Fak in anticancer combination therapies. Nat Rev Cancer. 2021;21(5):313\u201324. https:\/\/doi.org\/10.1038\/s41568-021-00340-6","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3362_CR54","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.21037\/jgo-22-86","volume":"13","author":"KL Aung","year":"2022","unstructured":"Aung KL, Mcwhirter E, Welch S, Wang L, Lovell S, Stayner LA, et al. A phase Ii trial of gsk2256098 and Trametinib in patients with advanced pancreatic ductal adenocarcinoma. J Gastrointest Oncol. 2022;13(6):3216\u201326. https:\/\/doi.org\/10.21037\/jgo-22-86","journal-title":"J Gastrointest Oncol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03362-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03362-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03362-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T03:00:46Z","timestamp":1742612446000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03362-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3362"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03362-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Guangdong Provincial People\u2019s Hospital (KY2024-579-01), and Sun Yat-sen Memorial Hospital (SYSEC-KY-KS-2021-177) and informed consent for tissue collection was obtained from each patient. All animal experiments were approved by the Animal Ethics Committee of the South China University (2021050).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent from all authors was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}